Explore
Validate
Learn
Other assayAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PAB0446 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#PAB0446, RRID:AB_982479
- Product name
- CRK (phospho S41) polyclonal antibody
- Antibody type
- Polyclonal
- Description
- Rabbit polyclonal antibody raised against synthetic phosphopeptide of CRK.
- Storage
- Store at 4°C. For long term storage store at -20°C.Aliquot to avoid repeated freezing and thawing.
Submitted references Cortactin and Crk cooperate to trigger actin polymerization during Shigella invasion of epithelial cells.
Nck and Crk mediate distinct VEGF-induced signaling pathways that serve overlapping functions in focal adhesion turnover and integrin activation.
Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas.
Bougnères L, Girardin SE, Weed SA, Karginov AV, Olivo-Marin JC, Parsons JT, Sansonetti PJ, Van Nhieu GT
The Journal of cell biology 2004 Jul 19;166(2):225-35
The Journal of cell biology 2004 Jul 19;166(2):225-35
Nck and Crk mediate distinct VEGF-induced signaling pathways that serve overlapping functions in focal adhesion turnover and integrin activation.
Stoletov KV, Gong C, Terman BI
Experimental cell research 2004 Apr 15;295(1):258-68
Experimental cell research 2004 Apr 15;295(1):258-68
Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas.
Miller CT, Chen G, Gharib TG, Wang H, Thomas DG, Misek DE, Giordano TJ, Yee J, Orringer MB, Hanash SM, Beer DG
Oncogene 2003 Sep 11;22(39):7950-7
Oncogene 2003 Sep 11;22(39):7950-7
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Dot blot analysis of CRK (phospho S41) polyclonal antibody (Cat # PAB0446) on nitrocellulose membrane. 50 ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentration was 0.5 ug/mL. P-Pab : phospho-antibody; P-Peptide : phospho-peptide; NP-Peptide : non-phospho-peptide.
- Validation comment
- Dot Blot (Peptide)
